Cargando…

Progress in medicinal chemistry. 5 /

PROGRESS IN MEDICINAL CHEMISTRY 5.

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Ellis, G. P. (Gwynn Pennant), West, G. B. (Geoffrey Buckle), 1916-1990
Formato: Electrónico eBook
Idioma:Inglés
Publicado: London : Butterworths, 1967.
Colección:Progress in medicinal chemistry ; 5
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 a 4500
001 SCIDIR_ocn297175118
003 OCoLC
005 20231117033224.0
006 m o d
007 cr cnu---unuuu
008 090106s1967 enka ob 001 0 eng d
040 |a N$T  |b eng  |e pn  |c N$T  |d N$T  |d OCLCQ  |d IDEBK  |d OCLCQ  |d E7B  |d OPELS  |d OCLCQ  |d OCLCF  |d OCLCQ  |d OCLCA  |d LEAUB  |d VLY  |d OCLCO  |d OCLCQ  |d OCLCO 
019 |a 646756461  |a 1162102276 
020 |a 9780080862538  |q (electronic bk.) 
020 |a 0080862535  |q (electronic bk.) 
020 |a 0444533249  |q (electronic bk.) 
020 |a 9780444533241  |q (electronic bk.) 
020 |a 1281715980 
020 |a 9781281715982 
020 |a 9786611715984 
020 |a 6611715983 
035 |a (OCoLC)297175118  |z (OCoLC)646756461  |z (OCoLC)1162102276 
050 4 |a RS403  |b .P76eb vol. 5 
072 7 |a MED  |x 023000  |2 bisacsh 
072 7 |a MED  |x 071000  |2 bisacsh 
072 7 |a MED  |x 072000  |2 bisacsh 
072 7 |a MED  |x 058170  |2 bisacsh 
082 0 4 |a 615/.19  |2 22 
245 0 0 |a Progress in medicinal chemistry.  |n 5 /  |c edited by G.P. Ellis and G.B. West. 
246 1 4 |a Progress in medicinal chemistry.  |n Volume 5 
260 |a London :  |b Butterworths,  |c 1967. 
300 |a 1 online resource (xi, 391 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 0 |a Progress in medicinal chemistry ;  |v 5 
504 |a Includes bibliographical references and index. 
588 0 |a Print version record. 
505 0 |a Front Cover; Progress in Medicinal Chemistry, Volume 5; Copyright Page; CONTENTS; Preface; CHAPTER 1. POLYPEPTIDE ANTIBIOTICS OF MEDICINAL INTEREST; 1. Introduction; 2. Classification of peptides; 3. Techniques of peptide chemistry; 4. Polypeptide antibiotics produced by B. brevis; 5. Peptide antibiotics pioduced by B. subtilis and B. licheniformis; 6. Polypeptide antibiotics produced by other strains of bacilli; 7. Polypeptide antibiotics produced by streptomyces; 8. Polypeptide antibiotics produced by fungi; 9. Polypeptide antibiotics isolated from different sources 
505 8 |a 10. Biosynthesis of polypeptide antibiotics11. Mechanism of action of polypeptide antibiotics; CHAPTER 2. NON-STEROIDAL ANTI-INFLAMMATORY DRUGS; 1. Introduction; 2. The nature and mechanism of inflammation; 3. Tests for anti-inflammatory activity; 4. Anti-inflammatory compounds; 5. Mode of action; 6. Uncoupling of oxidative phosphorylation; 7. Inhibition of hyaluronidase; 8. Stimulation of the adrenal cortex; 9. Chelation; 10. Hyperglycaemia; 11. Effects on immunological processes; CHAPTER 3. THE PHARMACOLOGY OF HEPARIN AND HEPARINOIDS; 1. Introduction 
505 8 |a 2. Complexing properties of heparin, heparinoids and mucopolysaccharides3. Biological reactions of heparin and heparinoids; 4. Anticoagulant activity; 5. Haemorrhage and thrombosis; 6. Chemical structure and biological activity; 7. Absorption, distribution and metabolism; 8. Toxicity; 9. Endogenous heparin and heparinoids; CHAPTER 4. THE HISTIDINE DECARBOXYLASES; 1. Introduction; 2. The measurement of histidine decarboxylase activity; 3. The substrate specificity of histidine decarboxylases; 4. The distribution of histidine decarboxylases 
505 8 |a 5. The mechanism of action of histidine decarboxylases6. Inhibition of histidine decarboxylation in vitro; 7. Inhibition of histidine decarboxylation in vivo; 8. Factors which modify the histidine decarboxylase activity of tissues; 9. The physiological function of histidine decarboxylases; 10. Concluding remarks; CHAPTER 5. PSYCHOT'ROPIC DRUGS AND NEUROHUMORAL SUBSTANCES IN THE CENTRAL NERVOUS SYSTEM; 1. Introduction; 2. The physiological background; 3. Humoral factors in the brain; 4. Classification and properties of the psychotropic drugs; 5. Psychotropic drugs and neurohumoral processes 
505 8 |a 6. ConclusionsCHAPTER 6. THE NITROFURANS; 1. Introduction to historical development; 2. Chemical and physical properties of nitrofuran compounds; 3. Synthesis of nitrofurans; 4. Toxicology, pharmacology and tolerancv; 5. Assays of nitrofurans; 6. Metabolism of nitrofurans; 7. Antibacterial properties in vitro; 8. Antibacterial properties in vivo; Addendum; Index 
520 |a PROGRESS IN MEDICINAL CHEMISTRY 5. 
546 |a English. 
650 0 |a Pharmaceutical chemistry. 
650 2 |a Chemistry, Pharmaceutical  |0 (DNLM)D002626 
650 6 |a Chimie pharmaceutique.  |0 (CaQQLa)201-0028674 
650 7 |a MEDICAL  |x Drug Guides.  |2 bisacsh 
650 7 |a MEDICAL  |x Pharmacology.  |2 bisacsh 
650 7 |a MEDICAL  |x Pharmacy.  |2 bisacsh 
650 7 |a MEDICAL  |x Nursing  |x Pharmacology.  |2 bisacsh 
650 7 |a Pharmaceutical chemistry  |2 fast  |0 (OCoLC)fst01060115 
700 1 |a Ellis, G. P.  |q (Gwynn Pennant) 
700 1 |a West, G. B.  |q (Geoffrey Buckle),  |d 1916-1990. 
776 0 8 |i Print version:  |t Progress in medicinal chemistry. 5.  |d London : Butterworths, 1967  |z 9780444533241  |w (OCoLC)18802386 
856 4 0 |u https://sciencedirect.uam.elogim.com/science/book/9780444533241  |z Texto completo